Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00754000 · ClinicalTrials.gov registry record
The AIM Study: Assessing the Impact of Margin Reduction
A clinical trial, sponsored by Varian, a Siemens Healthineers Company.
- Completed
- Registry status
- 82
- Enrollment target
NCT00754000 is a clinical trial that has completed, run by Varian, a Siemens Healthineers Company. The registered enrollment target is 82 participants.
The verdict
NCT00754000 has completed, sponsored by Varian, a Siemens Healthineers Company.
- COMPLETED
- Registry status
- 82 participants
- Enrollment target
Study Summary
This study will observe patients who receive external beam radiation for prostate cancer. These patients will be localized and tracked (targeted) with the Calypso 4D Localization System. These patients will have a uniform treatment plan with reduced PTVs (prostate treatment volume) and will be assessed at multiple time points for quality of life and side effects related to radiation therapy.
Interventions
- OTHER Observation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2008-07 |
| Est. Completion | 2009-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00754000
The ClinicalTrials.gov registry entry for NCT00754000 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Varian, a Siemens Healthineers Company, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Observation is the first listed.
NCT00754000 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00754000 about?
NCT00754000 is a clinical study titled "The AIM Study: Assessing the Impact of Margin Reduction". This study will observe patients who receive external beam radiation for prostate cancer. These patients will be localized and tracked (targeted) with the Calypso 4D Localization System. These patients will have a uniform treatment plan with reduced PTVs (prostate treatment volume) and will be asses...
What is the current status of trial NCT00754000?
This trial is currently completed. The enrollment target is 82 participants. The study started on 2008-07. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00754000?
The interventions under investigation include: Observation (OTHER).
Who is sponsoring clinical trial NCT00754000?
This trial is sponsored by Varian, a Siemens Healthineers Company, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.